Abstract
Down's syndrome (DS) is a human genetic disease caused by triplication of the distal third of chromosome 21 and overexpression of an unknown number of genes residing in it. The gene for the liver-type subunit of phosphofructokinase (PFKL), a key glycolytic enzyme, maps to this region and the product is overproduced in DS erythrocytes and fibroblasts. These facts, together with abnormalities which occur in DS glycolysis, make PFKL overexpression a candidate for causing some aspects of the DS phenotype. A cellular model for examining the consequences of PFKL overexpression in DS was constructed by transfecting rat PC12 cells with the human PFKL cDNA. Phosphofructokinase (PFK) isolated from PFKL-overexpressing clones was more inhibited by ATP and citrate and less activated by fructose-6-phosphate than control PFK; similar results were obtained when PFK preparations from DS and control fibroblasts were compared. In vivo NMR measurements determined that cells overexpressing PFKL performed glycolysis 40% faster than controls. These results show that overexpression of PFKL is the cause for altered biochemical regulatory characteristics of PFK in DS fibroblasts and can result in enhancement of glycolysis rates. It is also shown that increased gene dosage can exert its influence not merely by enhancing the amounts of gene products but also by altering their biochemical nature.
Similar content being viewed by others
Literature cited
Hook, E.B. (1981). InTrisomy 21 (Down Syndrome) Research and Perspective (eds.) De La Cruz, F.F., and Gerald, P.S. (University Park Press, Baltimore), pp. 3–68.
Epstein, C.J. (1986a).The Consequences of Chromosome Imbalance—Principles, Mechanisms and Models (Cambridge University Press, Cambridge).
Epstein, C.J. (ed.) (1986b).The Neurobiology of Down Syndrome. (Raven Press, New York).
Summitt, R.L. (1981). InTrisomy 21 (Down Syndrome) Research and Perspective (eds.) De La Cruz, F.F., and Gerald, P.S. (University Park Press, Baltimore), pp. 225–235.
Korenberg, J.R., Kawashima, H., Pulst, S.M., Allen, L., Magenis, E. and Epstein, C. (1990).Am. J. Med. Genet. Suppl. 791–97.
Carritt, B., and Litt, M. (1989).Cytogenet. Cell. Genet. 51358–371.
Uyeda, K. (1979).Adv. Enzymol. 48193–244.
Dunaway, G.A. (1983).Mol. Cell. Biochem. 5275–91.
Vora, S. (1982). InCurrent Topics in Biological and Medical Research, Vol. 6 (Alan R. Liss, New York), pp. 119–167.
Vora, S., and Francke, U. (1981).Proc. Natl. Acad. Sci. U.S.A. 78(6):3738–3742.
Van Keuren, M., Drabkin, H., Hart, I., Harker, D., Patterson, D., and Vora, S. (1986).Hum. Genet. 7434–40.
Cox, D.R., Kawashima, H., Vora, S., and Epstein, C. (1984).Cytogenet. Cell. Genet. 37441–442.
Vora, S., Miranda, A.F., Hernandez, E., and Francke, U. (1983).Hum. Genet. 63374–379.
Vora, S., Durham, S., de Martinville, B., George, D.L., and Francke, U. (1982).Somat. Cell Genet. 895–104.
Vora, S., Seaman, C., Durham, S., and Piomelli, S. (1980).Proc. Natl. Acad. Sci. U.S.A. 77(1):62–66.
Dunaway, G.A., Kasten, T.P., Sebo, T., and Trapp, R. (1988).Biochem. J. 251677–683.
Dunaway, G.A., and Kasten, T.P. (1988).Brain Res. 456310–316.
Dunaway, G.A., and Kasten, T.P. (1989).Mol. Cell. Biochem. 8771–77.
Dunaway, G.A., Kasten, T.P., Crabtree, S., and Mishkar, Y. (1990).Biochem. J. 266823–827.
Davidson, M., Collins, M., Byrne, J., and Vora, S. (1983).Biochem. J. 214703–710.
Staal, G.E.J., Kalff, A., Heesbeen, E.C., van Veelen, C.W.M., and Rijksen, G. (1987).Cancer Res. 475047–5051.
Oskam, R., Rijksen, G., Staal, G.E., and Vora, S. (1985).Cancer Res. 45135–142.
Vora, S., Halper, J.P., and Knowles, D.M. (1985).Cancer Res. 452993–3001.
Anneren, K.G., Korenberg, J.R., and Epstein, C.J. (1987).Hum. Genet. 7663–65.
Magnani, M., Stocchi, V., Novelli, G., Dacha, M., and Forniani, G. (1987).Clin. Physiol. Biochem. 59–14.
Lapidot, A., Gopher, A., Korman, S.H., and Mandel, H. (1990). Ninth Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine, New York (abstract).
Horwitz, B., Schapiro, M.B., Grady, C.L., and Rapoport, S.I. (1990).J. Ment. Def. Res. 34237–252.
Groner, Y., Elroy-Stein, O., Avraham, K.B., Yarom, R., Schikler, M., Knobler, H., and Rotman, G. (1990).J. Physiol. 8453–77.
Elroy-Stein, O., and Groner, Y. (1988).Cell 52259–267.
Minc-Golomb, D., Knobler, H., and Groner, Y. (1991).Embo J. 10(8):2119–2124.
Avraham, K.B., Schikler, M., Sapoznikov, D., Yarom, R., and Groner, Y. (1988).Cell 54823–829.
Avraham, K.B., Sugarman, H., Rotshenker, S., and Groner, Y. (1991).J. Neurocytol. 20208–215.
Schikler, M., Knobler, H., Avraham, K.B., Elroy-Stein, O., and Groner, Y. (1989).EMBO J. 8(5):1385–1392.
Levanon, D., Danciger, E., Dafni, N., Bernstein, Y., Elson, A., Moens, W., Brandeis, M., and Groner, Y. (1989).DNA 8(10):733–743.
Elson, A., Levanon, D., Brandeis, M., Dafni, N., Bernstein, Y., Danciger, E., and Groner, Y. (1990).Genomics 747–56.
Lee, F., Mulligan, R., Berg, P., and Ringold, G.Nature 294:228–231.
Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.E., Smith, J.A., and Struhl, K. (1989).Current Protocols in Molecular Biology (John Wiley & Sons, New York).
Chomczynski, P., and Sacchi, N. (1987).Anal. Biochem. 162156–159.
Weil, J., and Epstein, C.J. (1979).Hum. Genet. 31478–488.
Mosmann, T. (1983).J. Immunol. Methods 6555–63.
Kasten, T.P., Naqui, D., Kruep, D., and Dunaway, G.A. (1983).Biochem. Biophys. Res. Commun. 111(2):462–469.
Dunaway, G.A., and Kasten, T.P. (1985).J. Biol. Chem. 260(7):4180–4185.
Bradford, M.M. (1976).Anal. Biochem. 72248–254.
Towbin, H., Staehelin, T., and Gordon, J. (1979).Proc. Natl. Acad. Sci. U.S.A. 76(9):4350–4354.
Neeman, M., and Degani, H. (1989).Cancer Res. 49589–594.
Neeman, M., Rushkin, E., Kadouri, A., and Degani, H. (1988).Mag. Res. Med. 7236–242.
Mulligan, R.C., and Berg, P. (1980).Science 2091422–1427.
Southern, P.J., and Berg, P. (1982).J. Mol. Appl. Genet. 1327–341.
Greene, L.A., and Tischler, A.S. (1976).Proc. Natl. Acad. Sci. U.S.A. 73(7):2424–2428.
Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., and Danielsen, M. (1987).Proc. Natl. Acad. Sci. U.S.A. 847413–7417.
Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., and Erlich, H.A. (1988).Science 239487–491.
Lundberg, P., Harmsen, E., Ho, C., and Vogel, H.J. (1990).Anal. Biochem. 191193–222.
Sharma, P.M., Reddy, G.R., Vora, S., Babior, B.M., and McLachlan, A. (1989).Gene 77177–183.
Gonzalez, F., and Kemp, R.G. (1978).J. Biol. Chem. 253(5):1493–1497.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elson, A., Bernstein, Y., Degani, H. et al. Gene dosage and down's syndrome: Metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinase. Somat Cell Mol Genet 18, 143–161 (1992). https://doi.org/10.1007/BF01233161
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01233161